← Open Payments lookup

JUAN GUZMAN: Open Payments

NPI 1972521045 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$576 in 43 payments from 9 companies in 2025. Trend: 2023 $341 · 2024 $495 · 2025 $576

Food & beverage: $549Education: $27
CompanyPaymentsAmount
ABBVIE INC.32$309
E.R. Squibb & Sons, L.L.C.3$81
Axsome Therapeutics, Inc.2$37
Teva Pharmaceuticals USA, Inc.1$28
Lundbeck LLC1$27
Takeda Pharmaceuticals U.S.A., Inc.1$27
Vanda Pharmaceuticals Inc.1$26
Otsuka America Pharmaceutical, Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18

Products named: VRAYLAR, COBENFY, ABILIFY ASIMTUFII, Auvelity, UZEDY, TRINTELLIX, FANAPT, CAPLYTA.

Industry payments across CA — which companies pay providers there.